Integrating Radiation Therapy with Novel Immunotherapies in the Management of Brain Metastases and Leptomeningeal Disease
With improved systemic therapy, the management of brain metastasis has become increasingly important. A number of immunotherapies and targeted agents have shown blood brain barrier penetration with a potential role in the upfront management of brain metastases and leptomeningeal disease.
Category
  • Central Nervous System
  • Immunotherapy
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
ASTRO/SNO Joint Activity: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How?
The management of patients with grade 2 – 3 glioma has recently become even more complicated due to incorporation of molecular findings for pathologic diagnosis, changing criteria for who is considered high risk, and variability in the use and choice of chemotherapy with radiotherapy.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Empowering Survivorship: Addressing Pelvic Health Challenges in GI and GYN Cancer Patients Post-Radiation Therapy
Despite the increasing recognition of the long-term effects of radiation therapy on pelvic health, many healthcare providers remain inadequately trained to address these specific issues.
Category
  • Gastrointestinal
  • Gynecologic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Evolving Role of Consolidative Radiation Therapy for Gastrointestinal Malignancies
A subset of patients with limited metastatic cancer coined oligometastatic disease can benefit from aggressive local therapy, such as SABR, thus prolong survival by eradicating all sites of visible cancer.
Category
  • Gastrointestinal
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Gray Zone - Too Hot To Handle? Navigating the Dilemma of Radiation Necrosis after SRS for Brain Metastases
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
Pre-operative Radiotherapy in Locally Advanced Breast Cancer: A Narrative Review
This activity reviews the evolving role of pre‑operative (neoadjuvant) radiation therapy (preRT) in the management of locally advanced breast cancer (LABC).
Category
  • Breast
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
2026 Quarter 1 - Journal Reviewer CME
This activity is for Journal Reviewers that completed a review January - March 2026.
Category
  • Professional Development
Format
  • Journal Activities
Credits
  • 3.00 AMA PRA Category 1 Credit™
Cost $0.00
Challenging Cases in Palliative Care: Novel Therapeutics, Radioresistant Histology and Treatment Delivery
There are many ongoing advances in clinical care in the context of palliative radiation therapy delivery, clinical decision-making on treatment options, and clinical workflows in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.
Category
  • General RO
  • Palliative Care
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
ASTRO's Authorized User Training Center Program for Radiopharmaceutical Therapy Application
ASTRO’s AU Training Center Program provides radiation oncologists with a comprehensive, hands-on experience to meet Nuclear Regulatory Commission (NRC) and Agreement State requirements for Authorized User (AU) status in radiopharmaceutical therapy (RPT).
Category
  • Radiopharmaceutical Therapy
Format
Credits
Cost $0.00
Revisiting Post-Prostatectomy Salvage Radiation in the Age of Precision Oncology
This activity covers updates and evolving data in treating biochemically recurrent prostate cancer post-prostatectomy. One speaker covers fractionation: can we safely hypofractionate in the post-operative setting, or is the data more supportive of conventional fractionation?
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00

Pages